186 related articles for article (PubMed ID: 25535080)
1. PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release.
Halayqa M; Domańska U
Int J Mol Sci; 2014 Dec; 15(12):23909-23. PubMed ID: 25535080
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
3. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
4. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
[TBL] [Abstract][Full Text] [Related]
5. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
6. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
7. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
Mainardes RM; Evangelista RC
Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139
[TBL] [Abstract][Full Text] [Related]
8. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
9. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
Zhou YZ; Alany RG; Chuang V; Wen J
Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
11. Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables.
Mobarak DH; Salah S; Elkheshen SA
Pharm Dev Technol; 2014 Nov; 19(7):891-900. PubMed ID: 24032531
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
13. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
[TBL] [Abstract][Full Text] [Related]
15. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Wu W; Bi Y; Cai Z; Chen Q; Li Y; Hou S
Int J Pharm; 2008 Feb; 350(1-2):320-9. PubMed ID: 17913411
[TBL] [Abstract][Full Text] [Related]
16. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
Kim BS; Kim CS; Lee KM
Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
[TBL] [Abstract][Full Text] [Related]
17. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
Song X; Song SK; Zhao P; Wei LM; Jiao HS
Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
19. Development and physicochemical characterization of copper complexes-loaded PLGA nanoparticles.
Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Chuburu F
Int J Pharm; 2009 Sep; 379(2):226-34. PubMed ID: 19428198
[TBL] [Abstract][Full Text] [Related]
20. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
